3,900,000 Shares of Common Stock Jasper Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2024 • Jasper Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 6th, 2024 Company Industry Jurisdiction